|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0266 - 0.0285|
|52 Week Range||0.0005 - 0.1580|
|Beta (3Y Monthly)||61.66|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Creating Bioelastoplast natural rubber materials with improved performance for latex films and solid rubber dynamic applicationsIncorporating Single Walled Carbon Nano Tubes.
Vystar Corp. (OTC Market: VYST) has received a notice of allowance from Brazil for a patent titled “Natural Rubber Latex Having Reduced Allergenicity and Method of Making Same” regarding a process to remove proteins, lipids and lutoids from natural rubber latex (NRL). Vystar now holds 12 international and four domestic patents related to its latex deproteinization process which results in Vytex®, a natural rubber latex virtually free of allergen-causing latex proteins, thereby reducing risk of developing or experiencing allergic reactions from direct contact.
Vystar Corp. (OTC Market: VYST), the creator of Vytex deproteinized natural rubber latex and developer of environmentally friendly technologies and products, announced today that it has signed a definitive agreement and has acquired Murida Furniture Company, D/B/A Rotmans Furniture and Carpet (“Rotmans”). Rotmans, the largest furniture and flooring store in New England and one of the largest independent furniture retailers in the U.S., encompassing 200,000 square feet in Worcester, Mass., and employing 150 people, was founded and has been under the leadership of the Rotman family for the past 50 years. In 2018, Rotmans had gross revenue of approximately $30 plus million. Vystar has acquired a controlling interest in Rotmans for $2,030,000, comprised of 25% cash over 4-8 years and 75% in notes convertible into shares. Vystar desires to uplist to NASDAQ and expects any conversion of the notes into shares to take place after that event.
WORCESTER, Mass., June 10, 2019 -- Vystar® Corp. (OTC: VYST) and Competitive Edge Services LLC DBA Med Air Solutions (MAS) have signed an agreement whereby Med Air Solutions.
WORCESTER, Mass., June 03, 2019 -- Vystar Corp. (OTC Pink: VYST) extended and expanded its multi-year contract with Ranjit K. Matthan, Ph.D., an internationally renowned latex.
Vystar plans to apply Fluid Energy Conversion (FEC) technology to increase pathogen killing efficiency, reduce size and cost of Vystar’s RxAir air purifiers. FEC technology expected to be used to negate viruses and bacteria using sound energy in a highly proprietary manner. Vystar plans to apply FEC technology to vape pens to improve substance delivery and control dosage.
Vystar Corporation, (OTC Pink: VYST) a family of eco-friendly brands including Vytex® Natural Rubber Latex (NRL) and RxAir® air purification products, announced that FirstFire Global Opportunities Fund, LLC (FirstFire), an institutional investor who previously provided funding to Vystar, has invested $200,000 in Vystar at $0.15 per restricted common share, a 250 percent premium to yesterday’s market close. The stock purchase has no rights for conversion or warrants associated with it.
Vystar Corporation, (OTC Pink: VYST) a family of eco-friendly brands including Vytex® Natural Rubber Latex (NRL) and RxAir® air purification products, announced that it has made payment of $142,000 including principal of $103,000, and interest of 12% and fees to retire the convertible promissory note held by PowerUp Lending Group, Ltd. (PowerUp) dated October 23, 2018. Since December of 2018, Vystar has paid off approximately $380,000 to PowerUp and has no additional notes with them.
WORCESTER, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Vystar Corp. (OTC Market: VYST) has been granted European, EP Patent No. 2238183 entitled “Natural Rubber Latex Having Reduced Allergenicity and Method of Making Same.” Vystar now holds 13 foreign and 4 U.S. patents related to its latex deproteinization process for the production of Vytex®, a natural rubber latex (NRL) that is virtually free of allergen-causing latex proteins, thereby reducing risk of developing or experiencing allergic reactions to latex from direct contact. “This patent extends important intellectual property (IP) protection for Vystar in the production and distribution of Vytex to Europe using the Vytex formula to meet the growing demand for low protein NRL for products including balloons, examination and surgical gloves, condoms, breather bags, latex tubing, probe covers, catheters, threads, foams, cold seal and pressure sensitive adhesives,” stated Steve Rotman, CEO of Vystar.
Destroys on first pass more than 99.97% of harmful airborne viruses and bacteria. Inactivates pathogens that cause measles, the common cold, MRSA (staph), whooping cough, TB, pneumonia and other antibiotic-resistant and viral infections.
Features longer-lasting, more effective UV light for more efficient inactivation of viruses and bacteriaRxAir available for medical, business and residentialRxAir now available.
Sustainably sourced Vytex latex for ultra-long life, yet completely biodegradable. WORCESTER, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Vystar® Corporation (VYST) today began the New England soft launch of Vytex® Cloud Bed-in-a-Box Collection of 100% all natural latex mattresses in three levels of support. The Bed-in-a-Box concept is a hit with consumers - transforming the $30 billion dollar a year mattress industry. Industry Bed-in-a-Box sales grew by 60% in 2017. In a society that is now comfortable with online sales and enjoys the convenience of to your door delivery, Bed-in-a-Box sales now account for nearly 30% of all mattress sales.
Vystar Corporation, (OTC Pink: VYST) a family of eco-friendly brands including Vytex® Natural Rubber Latex (NRL) and RxAir® air purification products, announced that the board has authorized a stock buyback plan of up to 250 million shares, which represents approximately half of the outstanding shares, and has paid off a $105,000 convertible note in cash to limit dilution. Vystar paid off the remaining outstanding Peak One convertible note, due January 22, 2019 for $105,000 in cash on December 19th, 2019.